Zhengye Biotechnology Holding (ZYBT) Payables (2023 - 2024)
Zhengye Biotechnology Holding (ZYBT) has disclosed Payables for 2 consecutive years, with $10.4 million as the latest value for Q4 2024.
- Quarterly Payables fell 46.75% to $10.4 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $10.4 million through Dec 2024, down 46.75% year-over-year, with the annual reading at $10.4 million for FY2024, 47.75% down from the prior year.
- Payables for Q4 2024 was $10.4 million at Zhengye Biotechnology Holding, down from $19.6 million in the prior quarter.
- The five-year high for Payables was $19.6 million in Q4 2023, with the low at $10.4 million in Q4 2024.